Literature DB >> 11887052

Washing of the residual solution of cardiopulmonary bypass circuit after coronary artery bypass grafting in idiopathic thrombocytopenic purpura.

H Ohno1, M Higashidate, T Yokosuka.   

Abstract

A 76-year-old female with chronic idiopathic thrombocytopenic purpura required coronary bypass grafting. Preoperative treatment with high-dose intravenous immunoglobulin at a dose of 0.4 g/kg/day raised the platelet count from 57,000 to 110,000/microL. After termination of cardiopulmonary bypass (CPB) the residual blood in the CPB circuit was washed to reduce total immunoglobulin G (IgG) level, including platelet-associated immunoglobulin G (PA-IgG), and returned to the patient. Intraoperative platelet transfusion was used due to a drop in platelet count to the pretreatment level. The postoperative level of IgG and PA-IgG remained significantly lower than preoperatively. The postoperative course was uneventful and without bleeding complications. Perioperative management of a patient with idiopathic thrombocytopenic purpura undergoing open-heart surgery is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11887052

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  3 in total

Review 1.  Retention of atherogenic lipoproteins in atherogenesis.

Authors:  M Gustafsson; C Flood; P Jirholt; J Borén
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

2.  Endobronchial hemorrhage after intubation with double-lumen endotracheal tube in a patient with idiopathic thrombocytopenic purpura for minimally invasive cardiac surgery: a case report.

Authors:  Hee Young Kim; Seung Hoon Baek; Kyoung Hoon Kim; Nam Won Kim
Journal:  Korean J Anesthesiol       Date:  2014-01-28

Review 3.  Primary PCI for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. A case report and review of the literature.

Authors:  Aleksandar N Neskovic; Ivan Stankovic; Predrag Milicevic; Aleksandar Aleksic; Alja Vlahovic-Stipac; Branko Calija; Biljana Putnikovic
Journal:  Herz       Date:  2010-02-09       Impact factor: 1.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.